Sunitinib Viasana

Medicinal product

(Invented) name

Sunitinib Viasana

Active substance (s)

Sunitinibas

Strength

12,5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX01, sunitinib

Marketing authorisation holder

UAB Viasana, Lietuva

Date of authorisation

2022-02-08

Date of renewal

Documents

4904-4906 pakuotes lapelis_2022-02-08.docx

4904_4905_4906_Sunitinib Viasana-t.docx

Sunitib_Viasana_PAR+Scientific discus+LT apzvalga.pdf

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

LT/H/0160/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Sunitinibas	12,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108047	94151	1094151	lizdinė plokštelė	N30		Receptinis	LT/1/22/4904/001	Netiekiama	-	-	No	-	-
108048	94152	1094152	buteliukas	N30		Receptinis	LT/1/22/4904/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-12-31	Išregistruotas
2022-02-08	Registruotas